Cross appointments

Does not hold any cross appointments.

Research achievements

Research summary

The research program in Dr. Ji’s lab focuses on viral genetics and molecular epidemiology involving HIV and SARS-COV-2.

The primary research directions in the lab include:

  • Development and implementation of novel technologies HIV resistance testing and HIV diagnosis in general
  • Revolution of molecular viral characterization strategies in support of enhanced viral disease outbreak investigation and surveillance in the next generation sequencing era
  • Advanced research on viral diversity and molecular evolution of HIV and SARS-COV-2.

Research themes

  • HIV drug resistance
  • Viral genetics
  • Molecular epidemiology
  • New lab technology development


  • Viral genetics
  • Drug resistance
  • Molecular epidemiology
  • Viral evolution
  • Next generation sequencing

Research affiliations

  • Research scientist, National Microbiology Laboratory at JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada


Dr. Ji is an adjunct professor in the department of medical microbiology and infectious diseases at the University of Manitoba. He is also a senior research scientist and the head of the Viral Genetics Unit within the National HIV & Retrovirology Laboratories, National Microbiology Laboratory (NML) at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada.

Dr. Ji obtained systemic trainings in clinical medicine, medical immunology, medical microbiology and infectious diseases with over 28 years extensive research experiences in relevant fields.

Dr. Ji has been leading the NML effort in developing and implementing next generation sequencing (NGS)-based HIV drug resistance (HIVDR) testing technologies.

Besides developing NGS HIVDR assays, Dr. Ji was also one of the primary designers/developers for the HyDRA pipeline and HyDRA web portal.

Dr. Ji has devoted tremendous efforts to promote the implementation of NGS HIVDR testing in front-line labs.

Working with WHO/PAHO, Dr. Ji had led an international technology transfer project (2014~2017) in implementing NGS HIVDR technologies in regional and national HIVDR reference labs within the WHO/PAHO framework.

Dr. Ji hosted three international training workshops (in 2015, 2016 and 2017) on NGS HIVDR technologies with trainees from many Latin America & Caribbean, and Africa countries.

Dr. Ji was the initiator/organizer/host of the 2018 and 2019 International Symposia on NGS HIVDR, from which the “Winnipeg Consensus” on bioinformatics strategies for NGS-based HIVDR testing was established.

Beside developing new methodologies for HIV resistance testing, Dr. Ji’s lab also conducts in-depth research on viral genetics, molecular epidemiology and metagenomics involving HIV and SARS-COV-2. 

Dr. Ji is a member of the WHO Global HIV Drug Resistance Network working groups on Research and Innovation and Laboratory Capacity building.

Dr. Ji also serves as a panel member in many national and international research funding review panels, and as editor/reviewer for multiple international scientific journals.


Doctor of Philosophy (PhD) in Medical Microbiology & Infectious Diseases, University of Manitoba (2007)

Master of Science (MSc) in Medical Immunology, Hebei Medical University (1996)

Bachelor of Medicine (MD equivalent), Faculty of Medicine at Hebei North University (1993)


Scientific Excellence Award, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada (2019)

Science Co-op Supervisor Recognition Award from the University of British Columbia, Canada (2018)

Contact us

Medical Microbiology and Infectious Diseases
Max Rady College of Medicine
Room 543 - 745 Bannatyne Avenue
University of Manitoba (Bannatyne campus)
Winnipeg, MB R3E 0J9 Canada